The multinucleated osteoclast is the primary bone resorbing cell. Although much has been learned about bone resorption and calcium homeostasis, little is known about the cell biology of osteoclasts because of their relative inaccessability and fragility. Because of the abundant evidence that osteoclasts arise from cells of monocyte-macrophage lineage in the marrow, we have recently developed a long-term marrow system for studying the formation of osteoclast-like cells in human and baboon marrow. The marrow culture system utilizes the recently developed technique of long-term marrow culture, which provides an appropriate environment for normal marrow cell growth and maturation. These cultures are dependent on the formation of an adherent cell layer which duplicates the normal marrow microenvironment. We have found that 1,25 dihydroxycholecalciferol, an important differentiating agent for osteoclasts, stimulates the formation of multinucleated cells in these cultures. The multinucleated cells which formed have the functional and morphologic characteristics as well as the enzymatic profiles of osteoclasts. In this proposal we will use these marrow culture systems to: 1) compare the biologic and physical properties of these marrow multinucleated cells to authentic osteoclasts; 2) compare the growth characteristics of marrow-derived osteoclast-like cells in long-term cultures from fetal, neonatal, pubescent and adult baboon marrow; 3) compare the characteristics of human and baboon osteoclast-like cells formed in vitro; 4) enrich cell populations for the precursors of these osteoclast-like cells. As part of this goal we will initiate studies to prepare monoclonal antibody to human osteoclast-like cells; and 5) to identify and characterize the mononuclear precursor of these osteoclast-like cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases (NIADDK)
Type
Research Project (R01)
Project #
1R01AM035188-01
Application #
3153742
Study Section
Oral Biology and Medicine Study Section (OBM)
Project Start
1985-09-01
Project End
1988-08-31
Budget Start
1985-09-01
Budget End
1986-08-31
Support Year
1
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Type
Schools of Medicine
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Roodman, G D; Ohsaki, Y; Miller, M M et al. (1998) Pagetic osteoclasts formed in vitro: absence of paracrystalline inclusions. J Submicrosc Cytol Pathol 30:315-27
Choi, S J; Devlin, R D; Menaa, C et al. (1998) Cloning and identification of human Sca as a novel inhibitor of osteoclast formation and bone resorption. J Clin Invest 102:1360-8
Devlin, R D; Reddy, S V; Savino, R et al. (1998) IL-6 mediates the effects of IL-1 or TNF, but not PTHrP or 1,25(OH)2D3, on osteoclast-like cell formation in normal human bone marrow cultures. J Bone Miner Res 13:393-9
Reddy, S; Devlin, R; Menaa, C et al. (1998) Isolation and characterization of a cDNA clone encoding a novel peptide (OSF) that enhances osteoclast formation and bone resorption. J Cell Physiol 177:636-45
Roodman, G D (1996) Paget's disease and osteoclast biology. Bone 19:209-12
Reddy, S V; Singer, F R; Mallette, L et al. (1996) Detection of measles virus nucleocapsid transcripts in circulating blood cells from patients with Paget disease. J Bone Miner Res 11:1602-7
Reddy, S V; Alcantara, O; Roodman, G D et al. (1996) Inhibition of tartrate-resistant acid phosphatase gene expression by hemin and protoporphyrin IX. Identification of a hemin-responsive inhibitor of transcription. Blood 88:2288-97
Roodman, G D (1996) Advances in bone biology: the osteoclast. Endocr Rev 17:308-32
Alsina, M; Boyce, B; Devlin, R D et al. (1996) Development of an in vivo model of human multiple myeloma bone disease. Blood 87:1495-501
Alsina, M; Boyce, B F; Mundy, G R et al. (1995) An in vivo model of human multiple myeloma bone disease. Stem Cells 13 Suppl 2:48-50

Showing the most recent 10 out of 47 publications